Literature DB >> 21788013

Novel O-glycosidic gossypol isomers and their bioactivities.

Juanjuan Yin1, Limei Jin, Feng Chen, Xi Wang, Alex Kitaygorodskiy, Yueming Jiang.   

Abstract

Novel glycosidic gossypol analogs, 7,7'-gossypol diglucoside tetraacetate GS1, 6,7'-gossypol diglucoside tetraacetate GS2, 7,7'-gossypol diglycoside GS1', 6,7'-gossypol diglycoside GS2' were obtained by the ultrasound-assisted reaction of the potassium salt of gossypol with 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide under PTC conditions and were fully characterized by 1D NMR ((1)H NMR, (13)C NMR, DEPT, 1D NOE), 2D NMR (HMBC, HMQC), FTIR, HRMS and HPLC. The anticancer activities, cytotoxic effects as well as anti-trypanosomal activities of these novel glycosidic gossypols were explored and suggest that gossypol glycosides could be used to develop new candidates for anticancer drugs and anti-trypanosomal agents. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788013     DOI: 10.1016/j.carres.2011.06.031

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  2 in total

1.  Practical Strategy to 1,1'-Dideoxygossypol Derivatives from Gossypol and Its Antitumor Activities.

Authors:  Wei Wang; Yuzhi Lu; Juncheng Ge; Niya Liu
Journal:  ACS Omega       Date:  2022-06-22

2.  Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.

Authors:  Qing Yu; Zhiguo Hu; Yanwen Shen; Yihan Jiang; Peichen Pan; Tingjun Hou; Zhen-Qiang Pan; Jing Huang; Yi Sun
Journal:  Neoplasia       Date:  2020-04       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.